Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: Results from a population based study

Annals of the Rheumatic Diseases

Volumn 57, Issue 1, 1998, Pages 20-24

  Hay, Elaine M ^a   Thomas, E ^b   Pal, B ^c   Hajeer, Ali ^b   Chambers, H ^b   Silman, A J ^b  

^a Staffordshire Rheumatology Centre   (United Kingdom)

^b ARC Epidemiology Unit   (United Kingdom)

^c WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LACRIMAL GLAND; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SALIVARY GLAND; SALIVATION; SCHIRMER TEST; XEROSTOMIA;

EID: 0031899338     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.1.20     Document Type: Article

References (13)

1. Manthorpe R, Jacobsson LTH. Classification and assessment of rheumatic diseases: Part II: Sjögrens syndrome. Ballieres Clin Rheumatol 1995;9:483-96.
2. Workshop participants. Manual of methods - procedures. Clin Exp Rheumatol 1989;7:213-18.
3. Vitali C, Moutsopoulos HM, Bombardieri S, et al. The European Study Group on diagnostic criteria in Sjögrens syndrome: sensitivity and specificity of tests for ocular and oral involvement in Sjöqrens syndrome. Ann Rheum Dis 1994;53:637-47.
4. Cho P, Yap M, Schirmer Test - 11: A clinical study of its repeatability. Optom Vis Sci 1993;70:157-9.
5. Pastiides CA, Kitsios G, Karakostas KX, et al. Evaluation of tear break up time, Schirmer's-1 test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol 1989;7:155-7.
6. Heintze V, Birked D, Bjorn H. Secretion role and buffer effect of resting and stimulated whole saliva as a function of age and sex. Swed Dent J 1983;7:237-8.
7. Vitali C., Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögrens syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
8. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European Classification Criteria for Sjögrens syndrome in a series of clinically defined cases: results from a prospective multicentre study. Ann Rheum Dis 1996;55:116-21.
9. Drosos AA, Andropoulos AP, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Prevalence of primary Sjögrens syndrome in an elderly population. Br J Rheumatol 1988;27:123-7.
10. Montecucco C, Bestagno M, Cerino A, Caporali R, Carnevale R, Longni M, et al. Anti SS-B/La antibodies in Sjögrens Syndrome and related autoimmune diseases: results of a quantitative immunoassay using a highly purified antigen. Clin Exp Rheumatol 1989;7:5-11.
11. Harley JB, Alexander E, Blas WB, et al. Anti Ro (SS-A) and Anti La (SS-B) in patients with Sjögrens syndrome. Arthritis Rheum 1986;29:196-206.
12. Venables PJW, Shatties W, Peuse CT, et al. Anti La (SS-B): a diagnostic criterion for Sjögrens syndrome? Clin Exp Rheumatol 1989;7:181-4.
13. Jacobsson L, Hansen BU, Manthorpe R, et al. Association of dry eyes and dry mouth with anti Ro SS-A and and La/SS-B autoantibodies in normal adults. Arthritis Rheum 1992;35:1492-501.